BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10. [PMID: 30567928 DOI: 10.1126/scitranslmed.aap8914] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 37.7] [Reference Citation Analysis]
Number Citing Articles
1 [DOI: 10.1101/811737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Fois CAM, Le TYL, Schindeler A, Naficy S, McClure DD, Read MN, Valtchev P, Khademhosseini A, Dehghani F. Models of the Gut for Analyzing the Impact of Food and Drugs. Adv Healthc Mater 2019;8:e1900968. [PMID: 31592579 DOI: 10.1002/adhm.201900968] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
3 Proffitt C, Bidkhori G, Moyes D, Shoaie S. Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms 2020;8:E1381. [PMID: 32916966 DOI: 10.3390/microorganisms8091381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tozlu M, Cash B, Younes M, Ertan A. Dilemma in post-IBD patients with IBS-D symptoms: A 2020 overview. Expert Review of Gastroenterology & Hepatology 2021;15:5-8. [DOI: 10.1080/17474124.2021.1829469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Medina JM, Fernández-López R, Crespo J, Cruz F. Propionate Fermentative Genes of the Gut Microbiome Decrease in Inflammatory Bowel Disease. J Clin Med 2021;10:2176. [PMID: 34070019 DOI: 10.3390/jcm10102176] [Reference Citation Analysis]
6 Prasoodanan P K V, Sharma AK, Mahajan S, Dhakan DB, Maji A, Scaria J, Sharma VK. Western and non-western gut microbiomes reveal new roles of Prevotella in carbohydrate metabolism and mouth-gut axis. NPJ Biofilms Microbiomes 2021;7:77. [PMID: 34620880 DOI: 10.1038/s41522-021-00248-x] [Reference Citation Analysis]
7 Lin Y, Wang G, Yu J, Sung JJY. Artificial intelligence and metagenomics in intestinal diseases. J Gastroenterol Hepatol 2021;36:841-7. [PMID: 33880764 DOI: 10.1111/jgh.15501] [Reference Citation Analysis]
8 Saurman V, Margolis KG, Luna RA. Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder. Dig Dis Sci 2020;65:818-28. [PMID: 32056091 DOI: 10.1007/s10620-020-06133-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 15.5] [Reference Citation Analysis]
9 Du H, Wang D, Zhang X. Inflammatory bowel disease: A potential pathogenic factor of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110610. [PMID: 35908596 DOI: 10.1016/j.pnpbp.2022.110610] [Reference Citation Analysis]
10 Lett B, Costello S, Roberts-Thomson I. Analyzing the intestinal microbiome in inflammatory bowel disease: From RNA to multiomics. JGH Open 2020;4:779-81. [PMID: 33102743 DOI: 10.1002/jgh3.12374] [Reference Citation Analysis]
11 Agrawal M, Allin KH, Petralia F, Colombel JF, Jess T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat Rev Gastroenterol Hepatol 2022;19:399-409. [PMID: 35301463 DOI: 10.1038/s41575-022-00593-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Pan LL, Li BB, Pan XH, Sun J. Gut microbiota in pancreatic diseases: possible new therapeutic strategies. Acta Pharmacol Sin 2021;42:1027-39. [PMID: 33093569 DOI: 10.1038/s41401-020-00532-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
13 Mamieva Z, Poluektova E, Svistushkin V, Sobolev V, Shifrin O, Guarner F, Ivashkin V. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations? World J Gastroenterol 2022; 28(12): 1204-1219 [DOI: 10.3748/wjg.v28.i12.1204] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Selin KA, Hedin CRH, Villablanca EJ. Immunological networks defining the heterogeneity of inflammatory bowel diseases. J Crohns Colitis 2021:jjab085. [PMID: 33959743 DOI: 10.1093/ecco-jcc/jjab085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Gajula P, Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterol Dietol 2019;65:107-15. [PMID: 30746927 DOI: 10.23736/S1121-421X.19.02559-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gao B, Chi L, Zhu Y, Shi X, Tu P, Li B, Yin J, Gao N, Shen W, Schnabl B. An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies. Biomolecules 2021;11:530. [PMID: 33918473 DOI: 10.3390/biom11040530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Beheshti-Maal A, Shahrokh S, Ansari S, Mirsamadi ES, Yadegar A, Mirjalali H, Zali MR. Gut mycobiome: The probable determinative role of fungi in IBD patients. Mycoses 2021;64:468-76. [PMID: 33421192 DOI: 10.1111/myc.13238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N. The Bacterial Connection between the Oral Cavity and the Gut Diseases. J Dent Res 2020;99:1021-9. [PMID: 32464078 DOI: 10.1177/0022034520924633] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
19 Pratt M, Forbes JD, Knox NC, Bernstein CN, Van Domselaar G. Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data. Front Cell Dev Biol 2021;9:716604. [PMID: 34869308 DOI: 10.3389/fcell.2021.716604] [Reference Citation Analysis]
20 Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z, Fu W. Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy. Front Endocrinol 2022;13:815999. [DOI: 10.3389/fendo.2022.815999] [Reference Citation Analysis]
21 Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res 2021;2021:8030297. [PMID: 34337079 DOI: 10.1155/2021/8030297] [Reference Citation Analysis]
22 Bilal M, Ashraf S, Zhao X. Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. Front Nutr 2022;9:931458. [DOI: 10.3389/fnut.2022.931458] [Reference Citation Analysis]
23 He Q, Han C, Huang L, Yang H, Hu J, Chen H, Dou R, Ren D, Lin H. Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation. J Cell Mol Med 2020;24:9349-61. [PMID: 32628809 DOI: 10.1111/jcmm.15586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Fagundes RR, Bourgonje AR, Saeed A, Vich Vila A, Plomp N, Blokzijl T, Sadaghian Sadabad M, von Martels JZH, van Leeuwen SS, Weersma RK, Dijkstra G, Harmsen HJM, Faber KN. Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut Microbes 2021;13:1993582. [PMID: 34793284 DOI: 10.1080/19490976.2021.1993582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A. Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. Nutrients 2022;14:2520. [PMID: 35745251 DOI: 10.3390/nu14122520] [Reference Citation Analysis]
26 Ni Q, Ye Z, Wang Y, Chen J, Zhang W, Ma C, Li K, Liu Y, Liu L, Han Z, Gao T, Jian Z, Li S, Li C. Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With Vitiligo. Front Microbiol 2020;11:592248. [PMID: 33381090 DOI: 10.3389/fmicb.2020.592248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Yang J, Wu J, Li Y, Zhang Y, Cho WC, Ju X, van Schothorst EM, Zheng Y. Gut bacteria formation and influencing factors. FEMS Microbiol Ecol 2021;97:fiab043. [PMID: 33705527 DOI: 10.1093/femsec/fiab043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Nakane S, Mukaino A, Ihara E, Ogawa Y. Autoimmune gastrointestinal dysmotility: the interface between clinical immunology and neurogastroenterology. Immunological Medicine 2021;44:74-85. [DOI: 10.1080/25785826.2020.1797319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zuo W, Wang B, Bai X, Luan Y, Fan Y, Michail S, Sun F. 16S rRNA and metagenomic shotgun sequencing data revealed consistent patterns of gut microbiome signature in pediatric ulcerative colitis. Sci Rep 2022;12:6421. [PMID: 35440670 DOI: 10.1038/s41598-022-07995-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Xia Y, Wang J, Fang X, Dou T, Han L, Yang C. Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease. J Appl Microbiol 2021. [PMID: 34008889 DOI: 10.1111/jam.15154] [Reference Citation Analysis]
31 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
32 Lucarini E, Micheli L, Di Cesare Mannelli L, Ghelardini C. Naturally occurring glucosinolates and isothiocyanates as a weapon against chronic pain: potentials and limits. Phytochem Rev. [DOI: 10.1007/s11101-022-09809-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Li Q, Zhou S, Wang Y, Cong J. Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 2022;204:442. [PMID: 35776212 DOI: 10.1007/s00203-022-03069-4] [Reference Citation Analysis]
34 Park IJ, Lee JH, Kye BH, Oh HK, Cho YB, Kim YT, Kim JY, Sung NY, Kang SB, Seo JM, Sim JH, Lee JL, Lee IK. Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Med 2020;9:E2181. [PMID: 32664289 DOI: 10.3390/jcm9072181] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Caparrós E, Wiest R, Scharl M, Rogler G, Gutiérrez Casbas A, Yilmaz B, Wawrzyniak M, Francés R. Dysbiotic microbiota interactions in Crohn's disease. Gut Microbes 2021;13:1949096. [PMID: 34313550 DOI: 10.1080/19490976.2021.1949096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
36 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Reference Citation Analysis]
37 Nuzzo A, Saha S, Berg E, Jayawickreme C, Tocker J, Brown JR. Expanding the drug discovery space with predicted metabolite-target interactions. Commun Biol 2021;4:288. [PMID: 33674782 DOI: 10.1038/s42003-021-01822-x] [Reference Citation Analysis]
38 Li Y, Zhang T, Sun J, Liu N. Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Front Cell Infect Microbiol 2022;12:899845. [DOI: 10.3389/fcimb.2022.899845] [Reference Citation Analysis]
39 Hugerth LW, Andreasson A, Talley NJ, Forsberg AM, Kjellström L, Schmidt PT, Agreus L, Engstrand L. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut 2020;69:1076-84. [PMID: 31601615 DOI: 10.1136/gutjnl-2019-318717] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 21.0] [Reference Citation Analysis]
40 Yoon BJ, Oh HK, Lee J, Cho JR, Kim MJ, Kim DW, Kang SB. Effects of probiotics on bowel function restoration following ileostomy closure in rectal cancer patients: a randomized controlled trial. Colorectal Dis 2021;23:901-10. [PMID: 33247529 DOI: 10.1111/codi.15463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tokarz R, Hyams JS, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Shah S, Markowitz J, Baker SS, Rosh J, Baldassano RN, Kugathasan S, Walters T, Tagliafierro T, Sameroff S, Lee B, Che X, Oleynik A, Denson LA, Lipkin WI. Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis. Inflamm Bowel Dis 2019;25:1656-62. [PMID: 31112614 DOI: 10.1093/ibd/izz099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
42 von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study]. J Crohns Colitis 2020;14:595-607. [PMID: 31873717 DOI: 10.1093/ecco-jcc/jjz208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
43 Ren X, Xu J, Zhang Y, Chen G, Zhang Y, Huang Q, Liu Y. Bacterial Alterations in Post-Cholecystectomy Patients Are Associated With Colorectal Cancer. Front Oncol 2020;10:1418. [PMID: 32903396 DOI: 10.3389/fonc.2020.01418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers DMAE, Masclee AAM, Fu J, Kurilshikov A, Wijmenga C, Zhernakova A, Weersma RK. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11:362. [PMID: 31953381 DOI: 10.1038/s41467-019-14177-z] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 51.5] [Reference Citation Analysis]
45 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Norton SE, Leman JKH, Khong T, Spencer A, Fazekas de St Groth B, McGuire HM, Kemp RA. Brick plots: an intuitive platform for visualizing multiparametric immunophenotyped cell clusters. BMC Bioinformatics 2020;21:145. [PMID: 32293253 DOI: 10.1186/s12859-020-3469-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, Le Roy CI, Raygoza Garay JA, Finnicum CT, Liu X, Zhernakova DV, Bonder MJ, Hansen TH, Frost F, Rühlemann MC, Turpin W, Moon JY, Kim HN, Lüll K, Barkan E, Shah SA, Fornage M, Szopinska-Tokov J, Wallen ZD, Borisevich D, Agreus L, Andreasson A, Bang C, Bedrani L, Bell JT, Bisgaard H, Boehnke M, Boomsma DI, Burk RD, Claringbould A, Croitoru K, Davies GE, van Duijn CM, Duijts L, Falony G, Fu J, van der Graaf A, Hansen T, Homuth G, Hughes DA, Ijzerman RG, Jackson MA, Jaddoe VWV, Joossens M, Jørgensen T, Keszthelyi D, Knight R, Laakso M, Laudes M, Launer LJ, Lieb W, Lusis AJ, Masclee AAM, Moll HA, Mujagic Z, Qibin Q, Rothschild D, Shin H, Sørensen SJ, Steves CJ, Thorsen J, Timpson NJ, Tito RY, Vieira-Silva S, Völker U, Völzke H, Võsa U, Wade KH, Walter S, Watanabe K, Weiss S, Weiss FU, Weissbrod O, Westra HJ, Willemsen G, Payami H, Jonkers DMAE, Arias Vasquez A, de Geus EJC, Meyer KA, Stokholm J, Segal E, Org E, Wijmenga C, Kim HL, Kaplan RC, Spector TD, Uitterlinden AG, Rivadeneira F, Franke A, Lerch MM, Franke L, Sanna S, D'Amato M, Pedersen O, Paterson AD, Kraaij R, Raes J, Zhernakova A. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 2021;53:156-65. [PMID: 33462485 DOI: 10.1038/s41588-020-00763-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
48 Chen F, Yin YT, Zhao HM, Wang HY, Zhong YB, Long J, Liu DY. Sishen Pill Treatment of DSS-Induced Colitis via Regulating Interaction With Inflammatory Dendritic Cells and Gut Microbiota. Front Physiol 2020;11:801. [PMID: 32754049 DOI: 10.3389/fphys.2020.00801] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zheng P, Yang J, Li Y, Wu J, Liang W, Yin B, Tan X, Huang Y, Chai T, Zhang H, Duan J, Zhou J, Sun Z, Chen X, Marwari S, Lai J, Huang T, Du Y, Zhang P, Perry SW, Wong ML, Licinio J, Hu S, Xie P, Wang G. Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression. Adv Sci (Weinh) 2020;7:1902862. [PMID: 32274300 DOI: 10.1002/advs.201902862] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 19.5] [Reference Citation Analysis]
50 Hu M, Zhang X, Li J, Chen L, He X, Sui T. Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases. Front Microbiol 2022;13:940196. [DOI: 10.3389/fmicb.2022.940196] [Reference Citation Analysis]
51 Fernández-Tomé S, Marin AC, Ortega Moreno L, Baldan-Martin M, Mora-Gutiérrez I, Lanas-Gimeno A, Moreno-Monteagudo JA, Santander C, Sánchez B, Chaparro M, Gisbert JP, Bernardo D. Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease. Nutrients 2019;11:E2605. [PMID: 31683517 DOI: 10.3390/nu11112605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
52 Singh P, Lembo A. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:523-45. [PMID: 34304786 DOI: 10.1016/j.gtc.2021.03.003] [Reference Citation Analysis]
53 Ruigrok RAAA, Collij V, Sureda P, Klaassen MAY, Bolte LA, Jansen BH, Voskuil MD, Fu J, Wijmenga C, Zhernakova A, Weersma RK, Vich Vila A. The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1326-38. [PMID: 33515008 DOI: 10.1093/ecco-jcc/jjab020] [Reference Citation Analysis]
54 Ansari MH, Ebrahimi M, Fattahi MR, Gardner MG, Safarpour AR, Faghihi MA, Lankarani KB. Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome. BMC Microbiol 2020;20:123. [PMID: 32429898 DOI: 10.1186/s12866-020-01817-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
55 Hu S, Vich Vila A, Gacesa R, Collij V, Stevens C, Fu JM, Wong I, Talkowski ME, Rivas MA, Imhann F, Bolte L, van Dullemen H, Dijkstra G, Visschedijk MC, Festen EA, Xavier RJ, Fu J, Daly MJ, Wijmenga C, Zhernakova A, Kurilshikov A, Weersma RK. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD. Gut 2021;70:285-96. [PMID: 32651235 DOI: 10.1136/gutjnl-2019-319706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
56 Bushman FD, Conrad M, Ren Y, Zhao C, Gu C, Petucci C, Kim MS, Abbas A, Downes KJ, Devas N, Mattei LM, Breton J, Kelsen J, Marakos S, Galgano A, Kachelries K, Erlichman J, Hart JL, Moraskie M, Kim D, Zhang H, Hofstaedter CE, Wu GD, Lewis JD, Zackular JP, Li H, Bittinger K, Baldassano R. Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease. Cell Host Microbe 2020;28:422-433.e7. [PMID: 32822584 DOI: 10.1016/j.chom.2020.07.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Yang Q, Liu J, Wang X, Robinson K, Whitmore MA, Stewart SN, Zhao J, Zhang G. Identification of an Intestinal Microbiota Signature Associated With the Severity of Necrotic Enteritis. Front Microbiol 2021;12:703693. [PMID: 34489892 DOI: 10.3389/fmicb.2021.703693] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, Shanahan F, O'Toole PW. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption. Gastroenterology 2020;158:1016-1028.e8. [PMID: 31843589 DOI: 10.1053/j.gastro.2019.11.301] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 12.7] [Reference Citation Analysis]
59 Mobasheri A, Mahmoudian A, Kalvaityte U, Uzieliene I, Larder CE, Iskandar MM, Kubow S, Hamdan PC, de Almeida CS Jr, Favazzo LJ, van Loon LJC, Emans PJ, Plapler PG, Zuscik MJ. A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis? Curr Rheumatol Rep 2021;23:78. [PMID: 34716494 DOI: 10.1007/s11926-021-01042-6] [Reference Citation Analysis]
60 Bolte LA, Vich Vila A, Imhann F, Collij V, Gacesa R, Peters V, Wijmenga C, Kurilshikov A, Campmans-Kuijpers MJE, Fu J, Dijkstra G, Zhernakova A, Weersma RK. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut 2021;70:1287-98. [PMID: 33811041 DOI: 10.1136/gutjnl-2020-322670] [Cited by in Crossref: 54] [Cited by in F6Publishing: 29] [Article Influence: 54.0] [Reference Citation Analysis]
61 Yoshimatsu Y, Mikami Y, Kanai T. Bacteriotherapy for inflammatory bowel disease. Inflamm Regen 2021;41:3. [PMID: 33441186 DOI: 10.1186/s41232-020-00153-4] [Reference Citation Analysis]
62 Metwaly A, Reitmeier S, Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-022-00581-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
63 Davrandi M, Harris S, Smith PJ, Murray CD, Lowe DM. The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder. J Clin Immunol 2021. [PMID: 34731398 DOI: 10.1007/s10875-021-01165-6] [Reference Citation Analysis]
64 Gulyaeva A, Garmaeva S, Ruigrok RAAA, Wang D, Riksen NP, Netea MG, Wijmenga C, Weersma RK, Fu J, Vila AV, Kurilshikov A, Zhernakova A. Discovery, diversity, and functional associations of crAss-like phages in human gut metagenomes from four Dutch cohorts. Cell Rep 2022;38:110204. [PMID: 35021085 DOI: 10.1016/j.celrep.2021.110204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Wu J, Wu Y, Chen Y, Liu M, Yu H, Zhang Y, Wang T. Desmethylbellidifolin Attenuates Dextran Sulfate Sodium-Induced Colitis: Impact on Intestinal Barrier, Intestinal Inflammation and Gut Microbiota. Planta Med 2021. [PMID: 34098585 DOI: 10.1055/a-1506-3476] [Reference Citation Analysis]
66 Hou JJ, Wang X, Wang YM, Wang BM. Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review. Crit Rev Microbiol 2021;:1-18. [PMID: 34936854 DOI: 10.1080/1040841X.2021.2018401] [Reference Citation Analysis]
67 Goll R, Johnsen PH, Hjerde E, Diab J, Valle PC, Hilpusch F, Cavanagh JP. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome. Gut Microbes 2020;12:1794263. [PMID: 32991818 DOI: 10.1080/19490976.2020.1794263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Yang B, He M, Chen X, Sun M, Pan T, Xu X, Zhang X, Gong Q, Zhao Y, Jin Z, Cheng Z, Tang M. Acupuncture Effect Assessment in APP/PS1 Transgenic Mice: On Regulating Learning-Memory Abilities, Gut Microbiota, and Microbial Metabolites. Computational and Mathematical Methods in Medicine 2022;2022:1-20. [DOI: 10.1155/2022/1527159] [Reference Citation Analysis]
69 Lo Sasso G, Khachatryan L, Kondylis A, Battey JND, Sierro N, Danilova NA, Grigoryeva TV, Markelova MI, Khusnutdinova DR, Laikov AV, Salafutdinov II, Romanova YD, Siniagina MN, Vasiliev IY, Boulygina EA, Solovyeva VV, Garanina EE, Kitaeva KV, Ivanov KY, Chulpanova DS, Kletenkov KS, Valeeva AR, Odintsova AK, Ardatskaya MD, Abdulkhakov RA, Ivanov NV, Peitsch MC, Hoeng J, Abdulkhakov SR. Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients. Inflamm Bowel Dis 2021;27:418-33. [PMID: 32766755 DOI: 10.1093/ibd/izaa188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
70 Dehghanbanadaki H, Aazami H, Keshavarz Azizi Raftar S, Ashrafian F, Ejtahed HS, Hashemi E, Hoseini Tavassol Z, Ahmadi Badi S, Siadat SD. Global scientific output trend for Akkermansia muciniphila research: a bibliometric and scientometric analysis. BMC Med Inform Decis Mak 2020;20:291. [PMID: 33167984 DOI: 10.1186/s12911-020-01312-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Liu J, Huang S, Li G, Zhao J, Lu W, Zhang Z. High housing density increases stress hormone- or disease-associated fecal microbiota in male Brandt's voles (Lasiopodomys brandtii). Horm Behav 2020;126:104838. [PMID: 32791065 DOI: 10.1016/j.yhbeh.2020.104838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
72 Oliver A, El Alaoui K, Haunschild C, Avelar-Barragan J, Mendez Luque LF, Whiteson K, Fleischman AG. Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State. Microbiol Spectr 2022;10:e0003222. [PMID: 35475626 DOI: 10.1128/spectrum.00032-22] [Reference Citation Analysis]
73 Tao Z, Zhou X, Zhang Y, Pu W, Yang Y, Wei F, Zhou Q, Zhang L, Du Z, Wu J. Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-α-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy. Mediators Inflamm 2021;2021:1610251. [PMID: 33967625 DOI: 10.1155/2021/1610251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Chen L, Wang D, Garmaeva S, Kurilshikov A, Vich Vila A, Gacesa R, Sinha T, Segal E, Weersma RK, Wijmenga C, Zhernakova A, Fu J; Lifelines Cohort Study. The long-term genetic stability and individual specificity of the human gut microbiome. Cell 2021;184:2302-2315.e12. [PMID: 33838112 DOI: 10.1016/j.cell.2021.03.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Xu H, Liu M, Cao J, Li X, Fan D, Xia Y, Lu X, Li J, Ju D, Zhao H. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. J Immunol Res 2019;2019:7546047. [PMID: 31772949 DOI: 10.1155/2019/7546047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
76 Mkaouar H, Mariaule V, Rhimi S, Hernandez J, Kriaa A, Jablaoui A, Akermi N, Maguin E, Lesner A, Korkmaz B, Rhimi M. Gut Serpinome: Emerging Evidence in IBD. Int J Mol Sci 2021;22:6088. [PMID: 34200095 DOI: 10.3390/ijms22116088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Si X, Jia H, Liu N, Li J, Pan L, Wang J, Wu Z. Alpha-Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation via Wnt-Hippo Signaling. Mol Nutr Food Res 2022;66:e2100955. [PMID: 35220672 DOI: 10.1002/mnfr.202100955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Qian K, Chen S, Wang J, Sheng K, Wang Y, Zhang M. A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia muciniphila protects against dextran sulfate sodium-induced colitis in mice by enhancing intestinal barrier and modulating gut microbiota. Food Funct 2022;13:2216-27. [PMID: 35133390 DOI: 10.1039/d1fo04094d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Wang C, Li S, Hong K, Yu L, Tian F, Zhao J, Zhang H, Chen W, Zhai Q. The roles of different Bacteroides fragilis strains in protecting against DSS-induced ulcerative colitis and related functional genes. Food Funct 2021. [PMID: 34308455 DOI: 10.1039/d1fo00875g] [Reference Citation Analysis]
80 Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C, Rosevelt A, Muraleedharan CK, Gillilland MG 3rd, Imai J, Omi M, Bishu S, Kao JY, Alteri CJ, Barnich N, Schmidt TM, Nusrat A, Inohara N, Golob JL, Kamada N. Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction. Cell Rep 2022;40:111093. [PMID: 35858565 DOI: 10.1016/j.celrep.2022.111093] [Reference Citation Analysis]
81 Song W, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, Liu Y, Zhang HM, Guo W. Association of Gut Microbiota and Metabolites With Disease Progression in Children With Biliary Atresia. Front Immunol 2021;12:698900. [PMID: 34630385 DOI: 10.3389/fimmu.2021.698900] [Reference Citation Analysis]
82 Wei X, Zhang L, Zhang R, Koci M, Si D, Ahmad B, Cheng J, Wang J, Aihemaiti M, Zhang M. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions. Front Immunol 2020;11:1361. [PMID: 32695115 DOI: 10.3389/fimmu.2020.01361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Dietary Patterns and Gut Microbiota: the Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 2022:nmac029. [PMID: 35348593 DOI: 10.1093/advances/nmac029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Ye Y, Liu Y, Cheng K, Wu Z, Zhang P, Zhang X. Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides. Front Nutr 2022;9:810453. [PMID: 35634403 DOI: 10.3389/fnut.2022.810453] [Reference Citation Analysis]
85 Chen XY, Fan HN, Zhang HK, Qin HW, Shen L, Yu XT, Zhang J, Zhu JS. Rewiring of Microbiota Networks in Erosive Inflammation of the Stomach and Small Bowel. Front Bioeng Biotechnol 2020;8:299. [PMID: 32478040 DOI: 10.3389/fbioe.2020.00299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Ajayi A, Jolaiya T, Smith S. Evolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications. J Clin Med 2020;9:E2565. [PMID: 32784731 DOI: 10.3390/jcm9082565] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 van der Lelie D, Oka A, Taghavi S, Umeno J, Fan TJ, Merrell KE, Watson SD, Ouellette L, Liu B, Awoniyi M, Lai Y, Chi L, Lu K, Henry CS, Sartor RB. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. Nat Commun 2021;12:3105. [PMID: 34050144 DOI: 10.1038/s41467-021-23460-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Olbjørn C, Småstuen MC, Moen AEF. Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease. Microorganisms 2022;10:1273. [DOI: 10.3390/microorganisms10071273] [Reference Citation Analysis]
89 Wang J, Bleich RM, Zarmer S, Zhang S, Dogan B, Simpson KW, Arthur JC. Long-read sequencing to interrogate strain-level variation among adherent-invasive Escherichia coli isolated from human intestinal tissue. PLoS One 2021;16:e0259141. [PMID: 34710159 DOI: 10.1371/journal.pone.0259141] [Reference Citation Analysis]
90 Qiu Q, Wang J, Yan Y, Roy B, Chen Y, Shang X, Dou T, Han L. Metagenomic Analysis Reveals the Distribution of Antibiotic Resistance Genes in a Large-Scale Population of Healthy Individuals and Patients With Varied Diseases. Front Mol Biosci 2020;7:590018. [PMID: 33330625 DOI: 10.3389/fmolb.2020.590018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
91 Yu B, Wang L, Chu Y. Gut microbiota shape B cell in health and disease settings. J Leukoc Biol 2021;110:271-81. [PMID: 33974295 DOI: 10.1002/JLB.1MR0321-660R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 He JW, Zhou XJ, Hou P, Wang YN, Gan T, Li Y, Liu Y, Liu LJ, Shi SF, Zhu L, Lv JC, Zhang H. Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy. Front Cell Infect Microbiol 2021;11:652837. [PMID: 33869084 DOI: 10.3389/fcimb.2021.652837] [Reference Citation Analysis]
93 Guzzo GL, Andrews JM, Weyrich LS. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Wu YN, Zhang L, Chen T, Li X, He LH, Liu GX. Granulocyte-macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation. World J Gastroenterol 2020; 26(36): 5420-5436 [PMID: 33024394 DOI: 10.3748/wjg.v26.i36.5420] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Kundra P, Rachmühl C, Lacroix C, Geirnaert A. Role of Dietary Micronutrients on Gut Microbial Dysbiosis and Modulation in Inflammatory Bowel Disease. Mol Nutr Food Res 2021;65:1901271. [DOI: 10.1002/mnfr.201901271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
96 Wu F, Yang L, Hao Y, Zhou B, Hu J, Yang Y, Bedi S, Sanichar NG, Cheng C, Perez-Perez G, Tseng W, Tseng W, Tseng M, Francois F, Khan AR, Li Y, Blaser MJ, Shu XO, Long J, Li H, Pei Z, Chen Y. Oral and gastric microbiome in relation to gastric intestinal metaplasia. Int J Cancer 2021. [PMID: 34664721 DOI: 10.1002/ijc.33848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Galipeau HJ, Caminero A, Turpin W, Bermudez-brito M, Santiago A, Libertucci J, Constante M, Raygoza Garay JA, Rueda G, Armstrong S, Clarizio A, Smith MI, Surette MG, Bercik P, Croitoru K, Verdu EF, Beck P, Bernstein C, Croitoru K, Dieleman L, Feagan B, Griffiths A, Guttman D, Jacobson K, Kaplan G, Krause DO, Madsen K, Marshall J, Moayyedi P, Ropeleski M, Seidman E, Silverberg M, Snapper S, Stadnyk A, Steinhart H, Surette M, Turner D, Walters T, Vallance B, Aumais G, Bitton A, Cino M, Critch J, Denson L, Deslandres C, El-matary W, Herfarth H, Higgins P, Huynh H, Hyams J, Mack D, Mcgrath J, Otley A, Panancionne R. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology 2021;160:1532-45. [DOI: 10.1053/j.gastro.2020.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
98 Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, Festen EAM, Wijmenga C, Jonkers DMAE, Dijkstra G, Fu J, Zhernakova A, Imhann F, Weersma RK. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 2021;13:1943288. [PMID: 34313538 DOI: 10.1080/19490976.2021.1943288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
99 Luo X, Wang X, Huang S, Xu B, Luo S, Li Y, Wang Q, Chen Y, Deng X, Liu L, Zhou L. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway. Int Immunopharmacol 2021;90:107224. [PMID: 33302036 DOI: 10.1016/j.intimp.2020.107224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
101 Wei H, Deng S, Qin Y, Yang X, Chen T, Wang X, Xia Y. Insight Into the Potential Value of Gut Microbial Signatures for Prediction of Gestational Anemia. Front Cell Infect Microbiol 2021;11:734561. [PMID: 34527605 DOI: 10.3389/fcimb.2021.734561] [Reference Citation Analysis]
102 Li Y, Li N, Liu J, Wang T, Dong R, Ge D, Peng G. Gegen Qinlian Decoction Alleviates Experimental Colitis and Concurrent Lung Inflammation by Inhibiting the Recruitment of Inflammatory Myeloid Cells and Restoring Microbial Balance. JIR 2022;Volume 15:1273-91. [DOI: 10.2147/jir.s352706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Byrd KM, Gulati AS. The "Gum-Gut" Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances. Front Immunol 2021;12:620124. [PMID: 33679761 DOI: 10.3389/fimmu.2021.620124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
104 Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17:497-511. [PMID: 31249397 DOI: 10.1038/s41579-019-0213-6] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 64.5] [Reference Citation Analysis]
105 Baumgartner M, Lang M, Holley H, Crepaz D, Hausmann B, Pjevac P, Moser D, Haller F, Hof F, Beer A, Orgler E, Frick A, Khare V, Evstatiev R, Strohmaier S, Primas C, Dolak W, Köcher T, Klavins K, Rath T, Neurath MF, Berry D, Makristathis A, Muttenthaler M, Gasche C. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis. Gastroenterology 2021:S0016-5085(21)03138-3. [PMID: 34146566 DOI: 10.1053/j.gastro.2021.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Liu C, Huang S, Wu Z, Li T, Li N, Zhang B, Han D, Wang S, Zhao J, Wang J. Cohousing-mediated microbiota transfer from milk bioactive components-dosed mice ameliorate colitis by remodeling colonic mucus barrier and lamina propria macrophages. Gut Microbes 2021;13:1-23. [PMID: 33789528 DOI: 10.1080/19490976.2021.1903826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
107 Klaassen MAY, Imhann F, Collij V, Fu J, Wijmenga C, Zhernakova A, Dijkstra G, Festen EAM, Gacesa R, Vich Vila A, Weersma RK. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations. J Crohns Colitis 2019;13:1439-49. [PMID: 31066440 DOI: 10.1093/ecco-jcc/jjz077] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
108 Bromke MA, Krzystek-Korpacka M. Bile Acid Signaling in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:9096. [PMID: 34445800 DOI: 10.3390/ijms22169096] [Reference Citation Analysis]
109 Fine RL, Mubiru DL, Kriegel MA. Friend or foe? Lactobacillus in the context of autoimmune disease. Adv Immunol 2020;146:29-56. [PMID: 32327152 DOI: 10.1016/bs.ai.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Coquant G, Aguanno D, Pham S, Grellier N, Thenet S, Carrière V, Grill JP, Seksik P. Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions. World J Gastroenterol 2021; 27(42): 7247-7270 [PMID: 34876787 DOI: 10.3748/wjg.v27.i42.7247] [Reference Citation Analysis]
111 Vasapolli R, Schulz C, Schweden M, Casèn C, Kirubakaran GT, Kirste KH, Macke L, Link A, Schütte K, Malfertheiner P. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID). Eur J Clin Invest 2021;:e13666. [PMID: 34390492 DOI: 10.1111/eci.13666] [Reference Citation Analysis]
112 Chen L, Li R, Wang Z, Zhang Z, Wang J, Qiao Y, Huang Y, Liu W. Lactate-utilizing bacteria ameliorates DSS-induced colitis in mice. Life Sci 2022;288:120179. [PMID: 34838850 DOI: 10.1016/j.lfs.2021.120179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
113 Brunkwall L, Ericson U, Nilsson PM, Orho-Melander M, Ohlsson B. Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort. J Gastroenterol Hepatol 2021;36:174-80. [PMID: 32428346 DOI: 10.1111/jgh.15104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
114 Ji M, Huang H, Lan X, Shi Z. Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity. Disease Markers 2022;2022:1-6. [DOI: 10.1155/2022/1031844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Torres-Maravilla E, Reyes-Pavón D, Benítez-Cabello A, González-Vázquez R, Ramírez-Chamorro LM, Langella P, Bermúdez-Humarán LG. Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits. Microorganisms 2022;10:1389. [PMID: 35889107 DOI: 10.3390/microorganisms10071389] [Reference Citation Analysis]
116 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
117 Brand EC, Klaassen MAY, Gacesa R, Vich Vila A, Ghosh H, de Zoete MR, Boomsma DI, Hoentjen F, Horjus Talabur Horje CS, van de Meeberg PC, Willemsen G, Fu J, Wijmenga C, van Wijk F, Zhernakova A, Oldenburg B, Weersma RK; Dutch TWIN-IBD consortium and the Dutch Initiative on Crohn and Colitis. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients. Gastroenterology 2021;160:1970-85. [PMID: 33476671 DOI: 10.1053/j.gastro.2021.01.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
118 Shao HQ, Tan ZJ. Microbiota-targeted therapeutics in gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 841-848 [DOI: 10.11569/wcjd.v29.i15.841] [Reference Citation Analysis]
119 Zhan Y, Wen Y, Du L, Wang X, Tang S, Kong P, Huang W, Tang X. Effects of Maren Pills on the Intestinal Microflora and Short-Chain Fatty Acid Profile in Drug-Induced Slow Transit Constipation Model Rats. Front Pharmacol 2022;13:804723. [DOI: 10.3389/fphar.2022.804723] [Reference Citation Analysis]
120 Mujagic Z, Kasapi M, Jonkers DM, Garcia-Perez I, Vork L, Weerts ZZRM, Serrano-Contreras JI, Zhernakova A, Kurilshikov A, Scotcher J, Holmes E, Wijmenga C, Keszthelyi D, Nicholson JK, Posma JM, Masclee AA. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes 2022;14:2063016. [PMID: 35446234 DOI: 10.1080/19490976.2022.2063016] [Reference Citation Analysis]
121 Huang ST, Song ZJ, Liu Y, Luo WC, Yin Q, Zhang YM. BNSTAV GABA-PVNCRF Circuit Regulates Visceral Hypersensitivity Induced by Maternal Separation in Vgat-Cre Mice. Front Pharmacol 2021;12:615202. [PMID: 33815103 DOI: 10.3389/fphar.2021.615202] [Reference Citation Analysis]
122 Wu Y, Murray GK, Byrne EM, Sidorenko J, Visscher PM, Wray NR. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun 2021;12:1146. [PMID: 33608531 DOI: 10.1038/s41467-021-21280-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
123 Siniagina MN, Markelova MI, Boulygina EA, Laikov AV, Khusnutdinova DR, Abdulkhakov SR, Danilova NA, Odintsova AH, Abdulkhakov RA, Grigoryeva TV. Diversity and Adaptations of Escherichia coli Strains: Exploring the Intestinal Community in Crohn's Disease Patients and Healthy Individuals. Microorganisms 2021;9:1299. [PMID: 34203637 DOI: 10.3390/microorganisms9061299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Plichta DR, Graham DB, Subramanian S, Xavier RJ. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships. Cell. 2019;178:1041-1056. [PMID: 31442399 DOI: 10.1016/j.cell.2019.07.045] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 30.5] [Reference Citation Analysis]
125 Hajjo H, Geva-Zatorsky N. Strain-level immunomodulatory variation of gut bacteria. FEBS Lett 2021;595:1322-7. [PMID: 33570779 DOI: 10.1002/1873-3468.14057] [Reference Citation Analysis]
126 Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
127 Xu X, Feng X, He M, Zhang Z, Wang J, Zhu H, Li T, Wang F, Sun M, Wang Z. The effect of acupuncture on tumor growth and gut microbiota in mice inoculated with osteosarcoma cells. Chin Med 2020;15:33. [PMID: 32292489 DOI: 10.1186/s13020-020-00315-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
128 Collij V, Klaassen MAY, Weersma RK, Vila AV. Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications. Hum Genet 2021;140:703-8. [PMID: 32857194 DOI: 10.1007/s00439-020-02218-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Jiang P, Lai S, Wu S, Zhao XM, Chen WH. Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment. BMC Genomics 2020;21:348. [PMID: 32393180 DOI: 10.1186/s12864-020-6749-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
130 Hassouneh SA, Loftus M, Yooseph S. Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function. Front Microbiol 2021;12:673632. [PMID: 34349736 DOI: 10.3389/fmicb.2021.673632] [Reference Citation Analysis]
131 Jones-Nelson O, Tovchigrechko A, Glover MS, Fernandes F, Rangaswamy U, Liu H, Tabor DE, Boyd J, Warrener P, Martinez J, Hilliard JJ, Stover CK, Yu W, DAngelo G, Hess S, Cohen TS, Sellman BR. Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function. Antimicrob Agents Chemother 2020;64:e02347-19. [PMID: 32152087 DOI: 10.1128/AAC.02347-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Esquerre N, Basso L, Defaye M, Vicentini FA, Cluny N, Bihan D, Hirota SA, Schick A, Jijon HB, Lewis IA, Geuking MB, Sharkey KA, Altier C, Nasser Y. Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity. Cell Mol Gastroenterol Hepatol 2020;10:225-44. [PMID: 32289500 DOI: 10.1016/j.jcmgh.2020.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
133 Young RB, Marcelino VR, Chonwerawong M, Gulliver EL, Forster SC. Key Technologies for Progressing Discovery of Microbiome-Based Medicines. Front Microbiol 2021;12:685935. [PMID: 34239510 DOI: 10.3389/fmicb.2021.685935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Huang J, Wei S, Cheng N, Zhong Y, Yu F, Li M, Liu D, Li S, Zhao H. Chimonanthus nitens Oliv. Leaf Granule Ameliorates DSS-Induced Acute Colitis Through Treg Cell Improvement, Oxidative Stress Reduction, and Gut Microflora Modulation. Front Cell Infect Microbiol 2022;12:907813. [DOI: 10.3389/fcimb.2022.907813] [Reference Citation Analysis]
135 Liu J, Huang S, Zhang X, Li G, Batsuren E, Lu W, Xu X, He C, Song Y, Zhang Z. Gut microbiota reflect the crowding stress of space shortage, physical and non-physical contact in Brandt's voles (Lasiopodomys brandtii). Microbiol Res 2021;255:126928. [PMID: 34883384 DOI: 10.1016/j.micres.2021.126928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Agrawal M, Poulsen G, Colombel JF, Allin KH, Jess T. Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study. Gut 2022:gutjnl-2022-327724. [PMID: 35676084 DOI: 10.1136/gutjnl-2022-327724] [Reference Citation Analysis]
137 Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 2020;24:1263-82. [PMID: 33180654 DOI: 10.1080/14728222.2020.1841749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Bourgonje AR, Roo-Brand G, Lisotto P, Sadaghian Sadabad M, Reitsema RD, de Goffau MC, Faber KN, Dijkstra G, Harmsen HJM. Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera. Front Immunol 2022;13:842911. [PMID: 35693832 DOI: 10.3389/fimmu.2022.842911] [Reference Citation Analysis]
139 Wang L, Wang F, Zhang X, Chen Q, Xu J, Li H, Li F, Yang M, Konsue N. Transdermal Administration of Volatile Oil from Citrus aurantium-Rhizoma Atractylodis Macrocephalae Alleviates Constipation in Rats by Altering Host Metabolome and Intestinal Microbiota Composition. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9965334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Ke H, Li F, Deng W, Li Z, Wang S, Lv P, Chen Y. Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis. Front Pharmacol 2021;12:726707. [PMID: 34658866 DOI: 10.3389/fphar.2021.726707] [Reference Citation Analysis]
141 Yang M, Hong G, Jin Y, Li Y, Li G, Hou X. Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome. Front Cell Infect Microbiol 2020;10:515614. [PMID: 33224895 DOI: 10.3389/fcimb.2020.515614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:733992. [DOI: 10.3389/fcimb.2022.733992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
143 Yao Q, Li H, Fan L, Zhang Y, Zhao S, Zheng N, Wang J. Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease. Foods 2021;10:368. [PMID: 33567698 DOI: 10.3390/foods10020368] [Reference Citation Analysis]
144 Wu T, Li H, Su C, Xu F, Yang G, Sun K, Xu M, Lv N, Meng B, Liu Y, Hu L, Liu Y, Gao Y, Wang H, Lan Y, Xu D, Li J. Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages. mSystems 2020;5:e00587-20. [PMID: 33144310 DOI: 10.1128/mSystems.00587-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis 2022;14:e1540. [PMID: 35266651 DOI: 10.1002/wsbm.1540] [Reference Citation Analysis]
146 Ahmed M, Metwaly A, Haller D. Modeling microbe-host interaction in the pathogenesis of Crohn's disease. Int J Med Microbiol 2021;311:151489. [PMID: 33676240 DOI: 10.1016/j.ijmm.2021.151489] [Reference Citation Analysis]
147 Ghebretatios M, Schaly S, Prakash S. Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases. Int J Mol Sci 2021;22:1942. [PMID: 33669290 DOI: 10.3390/ijms22041942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut 2020;69:1510-9. [PMID: 32409589 DOI: 10.1136/gutjnl-2019-320204] [Cited by in Crossref: 119] [Cited by in F6Publishing: 86] [Article Influence: 59.5] [Reference Citation Analysis]
149 Hernandez J, Rhimi S, Kriaa A, Mariaule V, Boudaya H, Drut A, Jablaoui A, Mkaouar H, Saidi A, Biourge V, Borgi MA, Rhimi M, Maguin E. Domestic Environment and Gut Microbiota: Lessons from Pet Dogs. Microorganisms 2022;10:949. [DOI: 10.3390/microorganisms10050949] [Reference Citation Analysis]
150 Zhang F, He F, Li L, Guo L, Zhang B, Yu S, Zhao W. Bioavailability Based on the Gut Microbiota: a New Perspective. Microbiol Mol Biol Rev 2020;84:e00072-19. [PMID: 32350027 DOI: 10.1128/MMBR.00072-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
151 Hou JJ, Wang X, Li Y, Su S, Wang YM, Wang BM. The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome. Microb Pathog 2021;157:104995. [PMID: 34048892 DOI: 10.1016/j.micpath.2021.104995] [Reference Citation Analysis]
152 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
153 van Thiel IAM, de Jonge WJ, Chiu IM, van den Wijngaard RM. Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel. Am J Physiol Gastrointest Liver Physiol 2020;318:G1034-41. [PMID: 32308040 DOI: 10.1152/ajpgi.00196.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
154 Gravina AG, Dallio M, Romeo M, Di Somma A, Cotticelli G, Loguercio C, Federico A. Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation.Nutrients. 2020;12. [PMID: 32230832 DOI: 10.3390/nu12040928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]